Somatic and autonomic small fiber neuropathy induced by bortezomib therapy

An immunofluorescence study

Maria Pia Giannoccaro, Vincenzo Donadio, Carolina Gomis Pèrez, Walter Borsini, Vitantonio Di Stasi, Rocco Liguori

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Bortezomib is a new chemotherapeutic agent approved for the treatment of relapsed/refractory and newly diagnosed multiple myeloma. One of the major side effects of bortezomib is a peripheral length-dependent sensory axonal neuropathy and, less frequently, a small fiber neuropathy. Autonomic symptoms like postural dizziness, syncope, diarrhoea, ileus, impotence and urinary disturbances have been reported, nevertheless, autonomic neuropathy has never been characterized. We describe by means of immunofluorescence, the involvement of autonomic skin nerve fibers in three patients with small fiber neuropathy induced by bortezomib treatment.

Original languageEnglish
Pages (from-to)361-363
Number of pages3
JournalNeurological Sciences
Volume32
Issue number2
DOIs
Publication statusPublished - Apr 2011

Fingerprint

Fluorescent Antibody Technique
Autonomic Pathways
Ileus
Syncope
Dizziness
Erectile Dysfunction
Multiple Myeloma
Nerve Fibers
Diarrhea
Therapeutics
Skin
Bortezomib
Small Fiber Neuropathy

Keywords

  • Autonomic neuropathy
  • Bortezomib
  • Skin biopsy
  • Small fiber neuropathy
  • Velcade

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Cite this

Somatic and autonomic small fiber neuropathy induced by bortezomib therapy : An immunofluorescence study. / Giannoccaro, Maria Pia; Donadio, Vincenzo; Gomis Pèrez, Carolina; Borsini, Walter; Di Stasi, Vitantonio; Liguori, Rocco.

In: Neurological Sciences, Vol. 32, No. 2, 04.2011, p. 361-363.

Research output: Contribution to journalArticle

Giannoccaro, Maria Pia ; Donadio, Vincenzo ; Gomis Pèrez, Carolina ; Borsini, Walter ; Di Stasi, Vitantonio ; Liguori, Rocco. / Somatic and autonomic small fiber neuropathy induced by bortezomib therapy : An immunofluorescence study. In: Neurological Sciences. 2011 ; Vol. 32, No. 2. pp. 361-363.
@article{db0fdfcc02fc4ec79eb35b2f53e8ffff,
title = "Somatic and autonomic small fiber neuropathy induced by bortezomib therapy: An immunofluorescence study",
abstract = "Bortezomib is a new chemotherapeutic agent approved for the treatment of relapsed/refractory and newly diagnosed multiple myeloma. One of the major side effects of bortezomib is a peripheral length-dependent sensory axonal neuropathy and, less frequently, a small fiber neuropathy. Autonomic symptoms like postural dizziness, syncope, diarrhoea, ileus, impotence and urinary disturbances have been reported, nevertheless, autonomic neuropathy has never been characterized. We describe by means of immunofluorescence, the involvement of autonomic skin nerve fibers in three patients with small fiber neuropathy induced by bortezomib treatment.",
keywords = "Autonomic neuropathy, Bortezomib, Skin biopsy, Small fiber neuropathy, Velcade",
author = "Giannoccaro, {Maria Pia} and Vincenzo Donadio and {Gomis P{\`e}rez}, Carolina and Walter Borsini and {Di Stasi}, Vitantonio and Rocco Liguori",
year = "2011",
month = "4",
doi = "10.1007/s10072-010-0475-2",
language = "English",
volume = "32",
pages = "361--363",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "2",

}

TY - JOUR

T1 - Somatic and autonomic small fiber neuropathy induced by bortezomib therapy

T2 - An immunofluorescence study

AU - Giannoccaro, Maria Pia

AU - Donadio, Vincenzo

AU - Gomis Pèrez, Carolina

AU - Borsini, Walter

AU - Di Stasi, Vitantonio

AU - Liguori, Rocco

PY - 2011/4

Y1 - 2011/4

N2 - Bortezomib is a new chemotherapeutic agent approved for the treatment of relapsed/refractory and newly diagnosed multiple myeloma. One of the major side effects of bortezomib is a peripheral length-dependent sensory axonal neuropathy and, less frequently, a small fiber neuropathy. Autonomic symptoms like postural dizziness, syncope, diarrhoea, ileus, impotence and urinary disturbances have been reported, nevertheless, autonomic neuropathy has never been characterized. We describe by means of immunofluorescence, the involvement of autonomic skin nerve fibers in three patients with small fiber neuropathy induced by bortezomib treatment.

AB - Bortezomib is a new chemotherapeutic agent approved for the treatment of relapsed/refractory and newly diagnosed multiple myeloma. One of the major side effects of bortezomib is a peripheral length-dependent sensory axonal neuropathy and, less frequently, a small fiber neuropathy. Autonomic symptoms like postural dizziness, syncope, diarrhoea, ileus, impotence and urinary disturbances have been reported, nevertheless, autonomic neuropathy has never been characterized. We describe by means of immunofluorescence, the involvement of autonomic skin nerve fibers in three patients with small fiber neuropathy induced by bortezomib treatment.

KW - Autonomic neuropathy

KW - Bortezomib

KW - Skin biopsy

KW - Small fiber neuropathy

KW - Velcade

UR - http://www.scopus.com/inward/record.url?scp=79952898848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952898848&partnerID=8YFLogxK

U2 - 10.1007/s10072-010-0475-2

DO - 10.1007/s10072-010-0475-2

M3 - Article

VL - 32

SP - 361

EP - 363

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 2

ER -